← All Relmada Therapeutics, INC filings

Relmada Therapeutics, INC Form 4 insider transactions

NASDAQ
RLMD
Relmada Therapeutics, INC
Form 4: Relmada Therapeutics Director Paul Kelly Acquires and Forfeits Stock Options
Director Paul Kelly acquired and simultaneously forfeited stock options in Relmada Therapeutics on May 24, 2024, related to the company's 2021 Equity Incentive Plan.
NASDAQ
RLMD
Relmada Therapeutics, INC
Form 4: Relmada Therapeutics Director John Glasspool Acquires and Forfeits Stock Options
Director John Glasspool acquired and then forfeited stock options in Relmada Therapeutics on May 24, 2024, related to the company's 2021 Equity Incentive Plan.
NASDAQ
RLMD
Relmada Therapeutics, INC
Form 4: Relmada Therapeutics Director Fabiana Fedeli Acquires and Forfeits Stock Options
Director Fabiana Fedeli acquired and simultaneously forfeited stock options in Relmada Therapeutics on May 24, 2024, related to the company's 2021 Equity Incentive Plan.
NASDAQ
RLMD
Relmada Therapeutics, INC
Form 4: Relmada Therapeutics Officer Chuck Ence Reports Stock Option Transactions
Chuck Ence, an officer at Relmada Therapeutics, reported acquiring and forfeiting stock options related to the company's 2021 Equity Incentive Plan.
NASDAQ
RLMD
Relmada Therapeutics, INC
Form 4: Relmada Therapeutics Director Casamento Acquires and Forfeits Stock Options
Director Charles J. Casamento acquired and simultaneously forfeited stock options in Relmada Therapeutics on May 24, 2024, under the company's equity incentive plan.